GGrantIndex
← Leaderboards

Sally E Blank

New York University School Of Medicine

$145,946
Attributed
$145,946
Total exposure
14
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $58.5K · FY200508
$100K$75K$50K$25K$0
'05
'06
'07
'08

Funding mix

By agency

NIH$145,946 · 14

By mechanism

M01$145,946 · 14

Top collaborators

No co-investigators on record.

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Funding

Research focus

FundingSourceComputer Retrieval Of Information On Scientific Projects DatabaseResourcesUnited States National Institutes Of HealthResearch PersonnelInstitutionGrantResponseTumorToxic EffectCarcinomaOvarianEnd PointIn Complete RemissionEnrollmentMalignant Neoplasm Of OvaryPeritonealSpecimenCarboplatin/PaclitaxelStandards Of Weights And MeasuresPaclitaxelChemotherapyPrevention

Grant awards (16)

CLINICAL TRIAL: GOG-0209: COMPARING TWO REGIMENS IN PATIENTS WITH ENDOMETRIAL CA$3,250
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: OXALIPLATIN IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH CERV$1,354
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: OSI 774 WITH CARBOPLATIN AND PACLITAXEL IN OVARIAN OR PERITONEAL$948
M01 · FY2008 · RR · contact PI
GOG-0210: A MOLECULAR STAGING STUDY OF ENDOMETRIAL CARCINOMA$406
M01 · FY2008 · RR · contact PI
GOG-0199: USING SALPINGO-OOPHORECTOMY AND CA-125 TO SCREEN FOR OVARIAN CANCER$406
M01 · FY2008 · RR · contact PI
OSI 774 WITH CARBOPLATIN AND PACLITAXEL IN OVARIAN OR PERITONEAL CARCINOMA$30,772
M01 · FY2007 · RR · contact PI
OXALIPLATIN IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH CERVICAL CANCER$6,312
M01 · FY2007 · RR · contact PI
GOG-0199: USING SALPINGO-OOPHORECTOMY AND CA-125 TO SCREEN FOR OVARIAN CANCER$6,312
M01 · FY2007 · RR · contact PI
OSI 774 WITH CARBOPLATIN AND PACLITAXEL IN OVARIAN OR PERITONEAL CARCINOMA$42,086
M01 · FY2006 · RR · contact PI
OXALIPLATIN IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH CERVICAL CANCER$11,223
M01 · FY2006 · RR · contact PI
GOG-0199: USING SALPINGO-OOPHORECTOMY AND CA-125 TO SCREEN FOR OVARIAN CANCER$5,144
M01 · FY2006 · RR · contact PI
OSI 774 WITH CARBOPLATIN AND PACLITAXEL IN OVARIAN OR PERITONEAL CARCINOMA$24,350
M01 · FY2005 · RR
GOG-0199: USING SALPINGO-OOPHORECTOMY AND CA-125 TO SCREEN FOR OVARIAN CANCER$2,865
M01 · FY2005 · RR
OXALIPLATIN IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH CERVICAL CANCER$2,388
M01 · FY2005 · RR
OSI 774 with Carboplatin and Paclitaxel in Ovarian or Peritoneal Carcinoma$7,368
M01 · FY2004 · RR
GOG-0199: Using Salpingo-oophorectomy and CA-125 to Scr$762
M01 · FY2004 · RR